LeMaitre Vascular (LMAT) reported Q4 earnings late Thursday of $0.49 per diluted share, up from $0.38 a year earlier.
Analysts polled by FactSet expected $0.49.
Net sales in the three months ended Dec. 31 rose to $55.7 million from $48.9 million a year earlier.
Analysts surveyed by FactSet expected $56 million.
The company expects Q1 EPS of $0.48 to $0.53 on sales of $56.7 million to $58.7 million. Analysts expect EPS of $0.51 on sales of $58.1 million.
The company projects 2025 EPS of $2.15 to $2.32 on sales of $235.4 million to $242.8 million. Analysts forecast EPS $2.16 on sales of $240.2 million.
The company increased the quarterly dividend by $0.04 to $0.20 a share, payable March 27 to investors of record March 13.
Shares of the company fell 7.8% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.